Abstract 668: Deficiency of miR-155 Attenuates TLR3-Induced Preeclampsia-Like Symptoms in Mice

Hypertension ◽  
2014 ◽  
Vol 64 (suppl_1) ◽  
Author(s):  
Derek Charles ◽  
Ashley Jamison ◽  
Valorie L Chiasson ◽  
Brett M Mitchell ◽  
Piyali Chatterjee

Preeclampsia (PE) is one of the leading causes of maternal morbidity and mortality worldwide. PE is diagnosed by new onset hypertension and proteinuria or end-organ damage at or after mid-gestation. Although it is known that excessive maternal inflammation contributes to PE, the underlying mechanisms that cause hypertension during pregnancy are still unclear. Excessive maternal inflammation may be in part mediated by ligation of Toll-like receptors (TLRs) by pathogen- or danger-associated molecular patterns. MicroRNAs are small endogenous regulators of gene expression and recently numerous inflammation-related microRNAs have been identified. Several clinical studies reported that miR-155 expression, which is known to regulate inflammation in various disease conditions, is also up-regulated in the placentas of women with PE. We confirmed by qRT-PCR that miR-155 expression was significantly increased in formalin-fixed paraffin-embedded placentas from patients with PE compared to normal pregnant women. Poly I:C (a TLR3 agonist) treatment of human placental cytotrophoblasts (CTBs) for 24 hours significantly increased miR-155 expression compared to vehicle-treated CTBs. Based on these data we hypothesized that TLR3 activation induces placental miR-155 expression which in turn contributes to excessive maternal inflammation leading to PE whereas miR-155 deficiency will attenuate PE-like symptoms in a TLR3-induced PE mouse model. Pregnant WT and miR-155 KO mice were treated with poly I:C or saline on gestational days (gd) 13, 15, and 17 prior to sacrifice on gd 18. Poly I:C treatment induced hypertension in pregnant WT mice (P-PIC WT) (gd 17 SBP: 139±4 mmHg) compared to P WT mice (99±4 mmHg), however this was attenuated in P-PIC miR-155 KO mice (100±1 mmHg ). P-PIC WT mice exhibited endothelial dysfunction and splenomegaly compared to P WT mice and these were also attenuated in PPIC miR-155 KO mice. Our data taken together suggest that miR-155 plays a role in the pathogenesis of PE likely by increasing the maternal inflammatory response.

2014 ◽  
Vol 14 (3) ◽  
pp. 382-387 ◽  
Author(s):  
Juliana Fischer ◽  
Nathalie Canedo ◽  
Katia Goncalves ◽  
Leila Chimelli ◽  
Monique Franca ◽  
...  

Biomedicines ◽  
2021 ◽  
Vol 9 (2) ◽  
pp. 179
Author(s):  
Kristian Urh ◽  
Margareta Žlajpah ◽  
Nina Zidar ◽  
Emanuela Boštjančič

Significant progress has been made in the last decade in our understanding of the pathogenetic mechanisms of colorectal cancer (CRC). Cancer stem cells (CSC) have gained much attention and are now believed to play a crucial role in the pathogenesis of various cancers, including CRC. In the current study, we validated gene expression of four genes related to CSC, L1TD1, SLITRK6, ST6GALNAC1 and TCEA3, identified in a previous bioinformatics analysis. Using bioinformatics, potential miRNA-target gene correlations were prioritized. In total, 70 formalin-fixed paraffin-embedded biopsy samples from 47 patients with adenoma, adenoma with early carcinoma and CRC without and with lymph node metastases were included. The expression of selected genes and microRNAs (miRNAs) was evaluated using quantitative PCR. Differential expression of all investigated genes and four of six prioritized miRNAs (hsa-miR-199a-3p, hsa-miR-335-5p, hsa-miR-425-5p, hsa-miR-1225-3p, hsa-miR-1233-3p and hsa-miR-1303) was found in at least one group of CRC cancerogenesis. L1TD1, SLITRK6, miR-1233-3p and miR-1225-3p were correlated to the level of malignancy. A negative correlation between miR-199a-3p and its predicted target SLITRK6 was observed, showing potential for further experimental validation in CRC. Our results provide further evidence that CSC-related genes and their regulatory miRNAs are involved in CRC development and progression and suggest that some them, particularly miR-199a-3p and its SLITRK6 target gene, are promising for further validation in CRC.


2020 ◽  
Vol 9 (6) ◽  
pp. S53-S54
Author(s):  
Priyanka Karam ◽  
Yonah Ziemba ◽  
Sean Hacking ◽  
Karen Chau ◽  
Suganthi Soundararajan ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document